Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma

The treatment landscape of metastatic renal cell carcinoma (mRCC) has been transformed with the advent of antiangiogenics, notably tyrosine kinase inhibitors (TKIs) targeting vascular endothelial growth factor receptor (VEGFR), and immune checkpoint inhibitors (ICIs). Both treatment options have imp...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Adv Med Oncol
Main Authors: Rassy, Elie, Flippot, Ronan, Albiges, Laurence
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2020
Fag:
Challenging Dogma: New Evidence to Guide Practice in Urologic Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7081462/
https://ncbi.nlm.nih.gov/pubmed/32215057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920907504
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker